This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES Digital Week: Oligonucleotide & Peptide Therapeutics
May 2022

Macarena Hernández-Jiménez, Ph.D.
Chief Scientific Officer at AptaTargets S.L.

Agenda Sessions

  • First-in-Human Clinical Trial of ApTOLL, A New Aptamer to Reduce Inflammation